120 related articles for article (PubMed ID: 16952408)
1. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells.
Fan YZ; Chang H; Yu Y; Liu J; Zhao L; Yang DJ; Wang R
Biochim Biophys Acta; 2006 Oct; 1763(10):1059-66. PubMed ID: 16952408
[TBL] [Abstract][Full Text] [Related]
2. Human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, suppress proliferation and induce differentiation in HL-60 cells.
Zhao YL; Tao Y; Fu CY; Kong ZQ; Chen Q; Wang R
Peptides; 2009 Aug; 30(8):1514-22. PubMed ID: 19433125
[TBL] [Abstract][Full Text] [Related]
3. Increased radiation toxicity by enhanced apoptotic clearance of HL-60 cells in the presence of the pentapeptide thymopentin, which selectively binds to apoptotic cells.
Gonser S; Crompton NE; Folkers G; Weber E
Mutat Res; 2004 Mar; 558(1-2):19-26. PubMed ID: 15036115
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity of a potent thymopentin analog: disulphide bridged beta-mercaptopropionyl-arginyl-lysyl-aspartyl-valyl-tyrosyl-cysteine amide.
Wieczorek Z; Zimecki M; Trojnar J; Siemion IZ
Pol J Pharmacol; 1996; 48(1):31-8. PubMed ID: 9112625
[TBL] [Abstract][Full Text] [Related]
5. Saucernetin-7 isolated from Saururus chinensis inhibits proliferation of human promyelocytic HL-60 leukemia cells via G0/G1 phase arrest and induction of differentiation.
Seo BR; Lee KW; Ha J; Park HJ; Choi JW; Lee KT
Carcinogenesis; 2004 Aug; 25(8):1387-94. PubMed ID: 15033903
[TBL] [Abstract][Full Text] [Related]
6. Increased antitumor activity of tumor-specific peptide modified thymopentin.
Lao X; Li B; Liu M; Chen J; Gao X; Zheng H
Biochimie; 2014 Dec; 107 Pt B():277-85. PubMed ID: 25236717
[TBL] [Abstract][Full Text] [Related]
7. The in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2.
Li J; Cheng Y; Zhang X; Zheng L; Han Z; Li P; Xiao Y; Zhang Q; Wang F
Cancer Lett; 2013 Sep; 337(2):237-47. PubMed ID: 23684552
[TBL] [Abstract][Full Text] [Related]
8. TP5 triggers signal transduction involving mitogen activated protein kinases in monocytes.
Gonser S; Crompton NE; Weber PJ; Beck-Sickinger AG; Folkers G
J Recept Signal Transduct Res; 1999; 19(1-4):155-66. PubMed ID: 10071755
[TBL] [Abstract][Full Text] [Related]
9. Peptides and polypeptides as modulators of the immune response: thymopentin--an example with unknown mode of action.
Gonser S; Weber E; Folkers G
Pharm Acta Helv; 1999 Jun; 73(6):265-73. PubMed ID: 10443171
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
11. Expression of thymosin alpha1-thymopentin fusion peptide in Pichia pastoris and its characterization.
Gao D; Zhang X; Zhang J; Cao J; Wang F
Arch Pharm Res; 2008 Nov; 31(11):1471-6. PubMed ID: 19023544
[TBL] [Abstract][Full Text] [Related]
12. [Mediation of cellular immune response by TP5 in pathogenesis of myasthenia gravis].
He XT; Liu WB; Zhang Y; Huang X; Huang RX
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3337-40. PubMed ID: 20193562
[TBL] [Abstract][Full Text] [Related]
13. Vesicular phospholipid gels using low concentrations of phospholipids for the sustained release of thymopentin: pharmacokinetics and pharmacodynamics.
Zhong Y; Chen L; Zhang Y; Li W; Sun X; Gong T; Zhang Z
Pharmazie; 2013 Oct; 68(10):811-5. PubMed ID: 24273885
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin induces monocytic differentiation of HL-60 cells.
Li D; Wang Z; Chen H; Wang J; Zheng Q; Shang J; Li J
Free Radic Biol Med; 2009 Mar; 46(6):731-6. PubMed ID: 19110051
[TBL] [Abstract][Full Text] [Related]
15. Nardostachys chinensis induces granulocytic differentiation with the suppression of cell growth through p27(Kip1) protein-related G0/G1 phase arrest in human promyelocytic leukemic cells.
Ju SM; Lee J; Kang JG; Jeong SO; Park JH; Pae HO; Lee GS; Kim WS; Lyu YS; Jeon BH
Pharm Biol; 2015 Jul; 53(7):1002-9. PubMed ID: 25430995
[TBL] [Abstract][Full Text] [Related]
16. CD10 is expressed on human thymic epithelial cell lines and modulates thymopentin-induced cell proliferation.
Guérin S; Mari B; Fernandez E; Belhacene N; Toribio ML; Auberger P
FASEB J; 1997 Oct; 11(12):1003-11. PubMed ID: 9337153
[TBL] [Abstract][Full Text] [Related]
17. Myristic acid-modified thymopentin for enhanced plasma stability and immune-modulating activity.
Tan Y; Wang W; Wu C; Pan Z; Yao G; Fang L; Su W
Int Immunopharmacol; 2017 Jun; 47():88-94. PubMed ID: 28365509
[TBL] [Abstract][Full Text] [Related]
18. Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies.
Zhang T; Qin XY; Cao X; Li WH; Gong T; Zhang ZR
Acta Pharmacol Sin; 2019 Apr; 40(4):514-521. PubMed ID: 30002492
[TBL] [Abstract][Full Text] [Related]
19. The Protective Effects of Water-Soluble Alginic Acid on the N-Terminal of Thymopentin.
Ji H; Fan Y; Gao X; Gong Y; Dai K; Wang Z; Xu B; Yu J
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764221
[TBL] [Abstract][Full Text] [Related]
20. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte.
Lee KW; Kim HJ; Lee YS; Park HJ; Choi JW; Ha J; Lee KT
Carcinogenesis; 2007 Sep; 28(9):1928-36. PubMed ID: 17634406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
